We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
The Therapeutic Goods Administration (TGA) is seeking public comment on potential reforms to the regulation of nicotine vaping products in Australia. The potential reforms are aimed at preventing children and adolescents from accessing nicotine vaping products, while supporting access to products of known composition and quality for smoking cessation with a doctor’s prescription.
Evidence is emerging that more could be done to ensure that the reforms that commenced on 1 October 2021, which classified nicotine vaping products as prescription medicines, are meeting these aims. Children are continuing to access nicotine vaping products in higher numbers, and many adults are accessing them on the black market, rather than lawfully with a prescription from an Australian registered doctor.
Public comment on potential reforms is sought in four main areas:
- Changes to border controls for nicotine vaping products to curb the unlawful supply of nicotine vaping products in Australia
- Pre-market TGA assessment of nicotine vaping products against a product standard to create a regulated source of quality products to encourage doctors to prescribe, pharmacies to supply and vaping consumers to purchase safer and quality assured products lawfully
- Strengthening the product standard regarding minimum quality and safety standards for nicotine vaping products to make them less attractive to children and adolescents
- Clarifying the status of nicotine vaping products as therapeutic goods to ensure that any vaping product containing nicotine is captured by the regulatory framework.
The public consultation will be open until COB 16 January 2023 and feedback can be submitted via the TGA Consultation Hub. The responses will be analysed and any proposed reforms will be taken forward in discussion with the Government. If changes to the regulatory framework are made, suitable transition periods will apply.
Contact for members of the media:
Email: news@health.gov.au
Phone: 02 6289 7400